Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer [Phase 2]
Phase 2 trial of docetaxel, cisplatin, and fluorouracil in previously untreated locally advanced nasal cavity and paranasal sinus cancers; s…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer [NA]
A terminated clinical trial evaluating stereotactic body radiation therapy for high-risk locally advanced head and neck cancers; results wer…